Skip to main content
Get facts, not fiction
Published • loading... • Updated

Dyne Therapeutics (NASDAQ:DYN) Director Buys $40,000.00 in Stock

Summary by MarketBeat
Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) Director Brian Posner purchased 2,500 shares of the stock in a transaction on Friday, October 2nd. The shares were bought at an average cost of $16.00 per share, for a total transaction of $40,000.00. Following the transaction, the director directly owned 27,000 shares in the company, valued at approximately $432,000. The trade was a 10.20% increase in their ownership of the stock. The acqui…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Tuesday, October 6, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal